Related Experiment Video
Updated: Jun 6, 2025

07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
346
May-Hegglin anomaly associated nephropathy: Case series
Matthew D Nguyen1, Gayathri Dileep1, Marrey Quizon1
1Division of Nephrology, Hypertension and Transplant Nephrology, University of California, Irvine, CA, USA.
SAGE Open Medical Case Reports
|November 26, 2024
Summary
May-Hegglin anomaly (MHA), a genetic disorder, presents challenges in managing kidney complications due to low platelet counts. Genetic testing is crucial for diagnosis and understanding MHA-associated nephropathy.
Area of Science:
- Nephrology
- Genetics
- Hematology
Background:
- May-Hegglin anomaly (MHA) is a rare autosomal dominant disorder caused by MYH-9 gene mutations.
- It is characterized by macrothrombocytopenia, abnormal neutrophil inclusions, and potential systemic complications including renal failure.

